PTK2 and pancreatic neoplasm: To provide a potential avenue for optimized FAK targeting regimens and improved outcomes in this multifaceted and highly heterogeneous disease, we sought to first dissect the role that pharmacological FAK inhibition could have on stroma and epithelium in the complex microenvironment of pancreatic tumors.